Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
29,932
Total Claims
$6.6M
Drug Cost
1,228
Beneficiaries
$5,414
Cost/Patient
Risk Score Breakdown 16/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-98%
Opioid rate vs peers
0.0% vs 2.6% avg
+407%
Cost per patient vs peers
$5,414 vs $1,068 avg
+173%
Brand preference vs peers
24.6% vs 9.0% avg
Brand vs Generic
Brand: 7,263 claims · $5.6M
Generic: 22,272 claims · $999K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Diclofenac Epolamine | 1,155 | $1.0M |
| Tenofovir Alafenamide | 353 | $550K |
| Icosapent Ethyl | 799 | $548K |
| Semaglutide | 260 | $456K |
| Empagliflozin | 319 | $325K |
| Dapagliflozin Propanediol | 239 | $274K |
| Lipase/Protease/Amylase | 128 | $256K |
| Linaclotide | 273 | $222K |
| Sitagliptin Phosphate | 140 | $134K |
| Sitagliptin Phos/Metformin Hcl | 109 | $118K |
| Dexlansoprazole | 331 | $115K |
| Bepotastine Besilate | 437 | $101K |
| Apixaban | 84 | $92K |
| Finerenone | 75 | $90K |
| Cyclosporine | 125 | $88K |
Prescribing Profile
Patient Profile
74
Avg Age
52%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data